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ABSTRACT 
Metabolic syndrome has been defined as a global issue since it affects a lot of people. Numerous 
factors are involved in metabolic syndrome development. It has been described that metabolic 
syndrome has negative consequences on health. Consequently, a lot of treatments have been 
proposed to palliate it such as drugs, surgery or life style changes where nutritional habits have 
shown to be an important point in its management. The current study reviews the literature 
existing about the actual epidemiology of metabolic syndrome, the components involucrate in its 
appearance and progression, the clinical consequences of metabolic syndrome and the 
nutritional strategies reported in its remission. A bibliographic search in PubMed and Medline 
was performed to identify eligible studies. Authors obtained that metabolic syndrome is present 
in population from developed and undeveloped areas in a huge scale. Environmental and genetic 
elements are involucrate in metabolic syndrome development. Metabolic syndrome exponentially 
increased risk of cardiovascular disease, cancer, diabetes mellitus type 2, sleep disturbances, etc. 
Nutritional treatments play a crucial role in metabolic syndrome prevention and recovery.   
Keywords: Metabolic Syndrome; Obesity; Prevalence; Hyperglycemia; Inflammation; Diet; 
Cardiovascular Diseases.  
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RESUMEN 
El síndrome metabólico ha sido identificado como un problema global debido a que afecta a una 
gran cantidad de personas. Numerosos factores están involucrados en su aparición y desarrollo. 
Se ha descrito que el síndrome metabólico tendría consecuencias negativas en la salud. 
Consecuentemente, numerosos tratamientos han sido propuestos para paliar el síndrome 
metabólico como fármacos, cirugías o cambios en el estilo de vida donde los hábitos 
nutricionales serían un importante elemento en el control del síndrome metabólico. El presente 
estudio revisa la literatura existente sobre la epidemiología del síndrome metabólico, los 
componentes involucrados en su aparición y progresión, las consecuencias clínicas del mismo y 
las estrategias nutricionales utilizadas en su remisión. Se llevó a cabo una búsqueda bibliográfica 
en Pubmed y Medline con objeto de identificar estudios elegibles. Se obtuvo que el síndrome 
metabólico está presente en población tanto de países desarrollados como de países en vías de 
desarrollo. Factores medio ambientales y genéticos están involucrados en su desarrollo. Su 
padecimiento incrementa de forma exponencial el riesgo de padecer enfermedad cardiovascular, 
cáncer, diabetes mellitus tipo 2, anomalías del sueño, etc. Las estrategias nutricionales jugarían 
un papel esencial en la prevención y recuperación del síndrome metabólico.  
Palabras clave: Síndrome Metabólico; Obesidad; Prevalencia; Hiperglucemia; Inflamación; Dieta; 
Enfermedades Cardiovasculares.  
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 INTRODUCTION 
Metabolic syndrome (MS) is a recent concept in medicine; it was thirty years ago when it started 
to group the different MS components as a common pathology. In 1999, the World Health 
Organizations defined MS as the accumulation of hypertension, glucose intolerance, obesity and 
dyslipemia1 since then several diagnostic standards have been introduced. One of the most 
accepted is the definition of the National Cholesterol Education Program Adult Treatment Panel 
III (NEPATP III)2. This criterion describes MS as the presence of at least three risk factors. Risk 
factors are obesity (high waist circumference), triglyceride concentration (>150 mg/dL or drug 
treatment), low HDL cholesterol (<40 mg/dL in men and <50 mg/dL in women), high blood 
pressure (>130 mmHg systolic or >85 mmHg diastolic) and fasting blood glucose (>100 mg/dL 
or drug for DM). Similar definitions have been reported by the Japan Society for the Study of 
Obesity (JASSO) and the International Diabetes Federation (IDF), whereas in these models waist 
circumference is a required factor. Later, the American Heart Association (AHA), the National 
Heart, Lung and Blood Institute (NHLBI) and the IDF reported a new definition considering at 
least three risk factors where waist circumference was not a required factor. The main objective 
of this review was going further into different aspects of MS in order to shed some light on this 
syndrome. PubMed and Medline databases were searched to identify eligible studies 
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EPIDEMIOLOGY OF METABOLIC SYNDROME  
It has been reported that MS is already presented in almost all developed and undeveloped 
countries. Consequently it has become in a global health issue, preventive health procedures 
should be carried out. Young people affected by MS incidence will lead to an adult population 
with an increased risk for chronic diseases. Consequently, it would be really necessary to 
establish preventive strategies in young population in order to reduce possibilities to suffer MS.  
Generally, it is thought that MS is highly common in western countries, even it was estimated 
that more than 70% of adult population has at least one clinical sing of MS3. In 2009 a study 
mentioned that in US the prevalence of MS was 24% while in Europe was between 24.6-30.9%4. 
Another study5 determined MS prevalence in participants from the US, examining different 
variables of MS. They discovered that 38% showed MS and from them more than half presented 
severe MS. It is also the case that MS prevalence has been determined in US working subjects6, 
observing a high occurrence and MS subjects affected showed more health risks. Exactly, the 
prevalence of MS in Spain is 31% with little changes in function of gender7. The authors examined 
24.670 subjects from 10 areas to represent Spanish mature population. Furthermore, the 
prevalence of metabolic premorbid syndrome was 24% and this condition also increases coronary 
risk. Vosátková et al.8 determined the MS prevalence in population from the Czech Republic. They 
reported a mean value of 29.9% for women and 32.5% for men.   
Traditionally, countries with an oriental culture have been characterized by low prevalence of 
obesity, MS and chronic pathologies. However, one research9 investigated MS prevalence in 
Korean population; MS was 14.3% for parents and 7.2% for offspring. Song et al.10 studied the MS 
prevalence in 15.477 individuals from another oriental country, China. They detected a prevalence 
of 27.4%. It seems that one consequence of globalization may be the loss of protection of these 
areas against MS and chronic pathologies. Another research11 analyzed the MS incidence in 
Nigerian hypertensive patients. They observed a prevalence of 40.74% and the most common MS 
element was abdominal obesity. MS prevalence has been also analyzed in South America. A 
recent study12 studied MS affliction in Brazilian adult population. Obtaining that one in three 
subjects studied was diagnosed with MS. Additionally, more than half adult population from Chile 
has been classified with MS13. In Colombian population MS incidence has been also determined; 
obtaining that one third of participants studied suffered MS14.  
A crucial point in MS management is the prevalence in young population because MS rate has 
been increased among them in last times. A recent paper15 examined MS incidence in teenagers 
Rev Esp Nutr Hum Diet. 2017; 21(4).  Freely available online - OPEN ACCESS 
doi: 10.14306/renhyd.21.4.392 [ahead of print] 
6 
 
from Iran. They obtained that 6% of adolescents presented MS and sex variations were found 
(9.3% in man and 2.4% in woman). Furthermore, MS factors were very common, 42.4% have low 
HDL, hypertensive profile 16.3%, increased triglycerides concentration 15.6%, and high waist 
circumference 8.6%, etc. Rerksuppaphol et al.16 analyzed MS prevalence in obese children from 
Thailand. Half of them suffered MS and had high abdominal obesity, blood pressure, fasting 
glucose levels, triglycerides concentration and skinfolds thickness. The authors concluded that it 
would be necessary to treat and prevent MS in Thai children.  
ETIOLOGY AND DEVELOPMENT OF METABOLIC SYNDROME  
A huge cluster of factors may be involved in MS incidence: relatives, social-economic status, 
educational levels, genetic background, age, sex, hyperpalatable processed food environment, 
gut microbiota, dietary patterns and physical activity habits. These factors affects differently to 
each MS patient.  
It is really difficult define exactly which one would be the cause of MS. Interestingly, a review3 
suggested that several points could take part in MS prevalence such as age, genetic background, 
dietary patterns, physical activity habits and sex structure. As it could be thought environmental 
components could play an important role in MS development as can be seen in Figure 1. One 
study9 examined the effect of familial concordance in MS affliction. They observed that husbands 
whose wives presented MS exhibited 1.43 higher risk of suffering MS; wives whose husbands 
showed MS had 1.41 more chances of MS. Interestingly, children with at least one parent who 
experienced MS had 2.56 higher risks of MS, when both parents suffer MS, their children 
exhibited 3.31 higher possibilities of MS. Subsequently, MS affliction could increase risk of this 
condition in relatives.  Even, it has been proposed that belong to a specific ethnic group could 
affect to MS occurrence17.  
  
Rev Esp Nutr Hum Diet. 2017; 21(4).  Freely available online - OPEN ACCESS 
doi: 10.14306/renhyd.21.4.392 [ahead of print] 
7 
 
Rev Esp Nutr Hum Diet. 2017; 21(4).  Freely available online - OPEN ACCESS 
doi: 10.14306/renhyd.21.4.392 [ahead of print] 
8 
 
Other essential factors in MS development would be age and sex, one previous study18 examined 
age and sex importance in the clustering of MS factors. They analyzed men and women from US. 
MS prevalence was 26% in young and 55% in older population. In young male participant’s high 
triglycerides, low HDL cholesterol and elevated blood pressure were the most common factors 
while in young women were triglycerides, low HDL cholesterol and high waist circumference. 
However, in old population, the most prevalent combination was waist circumference, 
triglycerides, high blood pressure, low HDL cholesterol and impaired glucose tolerance. Sheu et 
al.19 communicated that specific MS elements could be used independently to predict MS 
affliction and these factors differ in function of sex. It seems likely that MS prevalence and 
expression could differ in function of age and sex. Bahrani and contributors15 reported that MS is 
significantly more widespread in obese population. They viewed positive correlation between MS 
in adolescent and parental education grade, domestic monthly earnings and school position. 
Even, a relation between a previous familiar obesity history and MS development was detected. 
Several investigations have proposed that genetic background could influence MS origin. 
Particularly, Alnory et al.20 studied the influence of specific polymorphisms in leptin and vaspin 
blood levels and the risk of suffering MS. A genotype of leptin polymorphisms was associated 
with metabolic risk development and high leptin concentration. Another study21 found that 
specific variations in FTO, SCG3 and MTMR9 genes could increase risk of MS. More recently, Zhao 
et al.22 refuted associations between genetic variations and MS. Even, it has been shown that MS 
elements could be connected with gut microbiota23. Changes in microbiota could improve MS. 
Philco et al.17 reported that depression could be considered a MS risk factor.  
Environmental factors play a crucial role in MS genesis. One research8 reported correlations 
between MS and consume of margarine, butter, fatty dairy products, low-fat dairy products, 
amount of daily meals and weight changes in the last ten years. For this reason, it would be 
necessary to address life style factors in the management of MS. Hunter et al.24 studied the effect 
of a high fat high sucrose diet (HFHSD), characteristic western diet. They obtained that the 
HFHSD increased oxidative stress and affected to cardiovascular function and remove female 
protection again cardiovascular dysfunction. Another research25 studied possible associations 
between soda ingestions and MS and diabetes mellitus type 2 (DMT2). They observed that daily 
soda consumption was connected to a 36% and 67 % risk increased of MS and DMT2 occurrence 
in contrast with non-intake. A study26 explored a possible association between MS affliction with 
nutritional habits in teenagers from USA. Better nutritional habits were connected with less MS 
prevalence. One interesting research27 analyzed food advertising on television, the authors found 
that 54.9% of advertising examined were about unbalanced energy profile or high in energy. 
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Even, the ratio between unbalanced energy profile or high energy food advertising and nutrient 
dense, low energy advertising was lower than a previous analysis six years before and this ratio 
was increased on thematic channels for children. Therefore, an exposure to unhealthy food would 
contribute to an unhealthy environment that might increase MS incidence. Furthermore, higher 
physical activity levels were related with lower MS prevalence. A lower fitness level has been 
associated to an increased risk of metabolic syndrome in children28. In addition, a lower level of 
physical exercise has been related with higher possibilities of occurrence of 
hypercholesterolemia, DMT2 and MS29. Additionally, it has been described a correlation between 
body composition measures, HDL-cholesterol and MS with insulin resistance in obese 
adolescents30. Subsequently, it would be recommended to evaluate insulin resistance in MS 
progression. Furthermore, MS has been associated with abdominal visceral fat distribution and 
higher levels of inflammation, quantified by interleukin-6, tumor necrosis factor- α and 
plasminogen activator inhibitor-1 in old obese subjects31.  
EFFECTS OF METABOLIC SYNDROME ON HEALTH 
MS increase comorbidities of other chronic pathologies such as DM, insulin resistance or some 
kinds of cancer, besides MS may amplify chance of cardiovascular diseases and sleep 
disturbances occurrence. MS suffering affects to quality of life because it increases physical 
incapability that could impact on daily activities of patients, consequently, MS could affect to 
health and quality of life of patients.  
A MS status maintained for long time has unquestionably effects on health increasing 
comorbidities as can be observed in Figure 1. MS affliction could be associated with higher risk of 
colon or rectal cancer as consequence of abdominal obesity and insulin resistance4. Particularly, 
the authors focus on this relation in high levels of leptin, low adiponectin, elevated C-peptide, 
high body mass index, elevated insulin growth factor-1, low insulin growth factor binding protein-
3 and hyperinsulinemia status. In addition, Harding et al.32 found that patients with five 
components of MS exhibited 1.12 and 2.07 increased risk for overall and colorectal cancer. Bjørge 
et al.33 analyzed women from Austria, Norway and Sweden to examine a possible connection 
between breast cancer and MS. They discovered that MS increased 1.23 risk of breast cancer 
mortality. Another study34 examined the MS prevalence in breast cancer patients. MS prevalence 
in breast cancer subjects was 59.2%, higher than in controls. More importantly, they found a 
positive and independent association between MS and breast cancer incidence (2.49). Another 
review35 determined that several factors characteristic of MS such as visceral adiposity, 
hyperglycemia, hyperinsulinemia, IGF-I, estrogen signaling and inflammation could be also 
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implicated in carcinogenesis and tumor evolution. The authors proposed that it would be 
essential to discern the possible connections between these factors and cancer risk, certainly 
methodological studies would be really necessary to comprehend the role of these determinants. 
Cowey and Hardy36 presented that elements from MS such as insulin resistance, adipokine 
formation or oxidative stress could collectively raise cancer risk.  
Guo et al.37 thought that it would be possible that MS could be related with a common 
gastrointestinal disorder, irritable bowel syndrome. They reported that irritable bowel syndrome 
was highly present in MS patients. It is also true that MS has been connected with the origin of 
chronic kidney disease38. The authors found that MS condition was involved in development of 
chronic disease dysfunction in Japanese population (ratio 2.12) and this risk was increased with 
more MS components accumulated. Furthermore, another study39 determined the repercussion 
of MS on long course kidney role and stone return rates after percutaneous nephrolithotomy. 
Authors obtained that MS profile was related with higher recurrence rates and worse renal 
function at long time after the operation. Moreover, it has been described that MS is connected 
with physical incapacity5. Another condition which has been related to MS is the sick euthyroid 
syndrome in adult population40. Another previous study41 mentioned that hyper-insulinemia, a 
highly factor present in MS, has been connected all aspects of polycystic ovary syndrome, a cause 
of infertility in women. Generally, it has been related MS with higher risk of cardiovascular 
disease. More significantly, MS could increase the chance to suffer atrial fibrillation, an usual 
arrhythmia42. Factors involved would be oxidative stress, high blood pressure, low grade of 
inflammation, left atrial and ventricular remodeling and activation of renin-angitensin-
aldosterone system. Another study7 declared that men and women who have MS present 2 and 
2.5 higher coronary risk, even coronary risk was increased in people with metabolic premorbid 
syndrome, 1.5 and 2 for men and women. Additionally, Rejeb et al.43 determined the relationship 
between MS and coronary stenosis in Tunisian participants. Coronary stenosis risk was 3.38 
higher in MS, this risk was increased with the number MS components and the highest was with 
five metabolic factors (4.48). Another research44 commented that people with MS presents a 1.5 
to 3 increase in the risk of suffering stroke and coronary heart disease.  
Recently, it has been suggested45 that people affected with mental disorders have more 
possibilities to suffer MS. The authors concluded that it was really common to be affected by MS 
in bipolar disorder patients. Moreover, it has been examined46 a possible relation between MS 
and the cognition level in elderly population using the Mini-mental State Examination (MMSE). 
Individuals with MS have lower MMSE scores and the numbers of MS factors could be an 
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independent predictor of lower MMSE scores. Additionally, biochemical modifications at cellular 
level produced in MS such as changes in endothelial cell activities, variations on fatty acid 
metabolism or irregular insulin and leptin metabolism could be related with neurological 
disorders as depression, Alzheimer´s disease and stroke47. Sasanabe et al.48 examined a possible 
relation between MS and sleep apnea. Men and women with obstructive sleep apnea syndrome 
exhibited a higher risk of MS. Even, psoriasis has been connected to metabolic syndrome, 
cytokines and adipocytokines could be in part responsible of this relation49.  A previous study6 
has observed that MS employees higher health-care and pharmaceutical cost and short-term 
disability. Even, MS subjects showed more productivity losses. MS suffering could do a worker less 
efficient and it would affect to company productivity. Another study50 reported that MS 
components, hyperglycemia and dyslipemia, could be connected with insulin resistance 
aggravation.  
NUTRITIONAL TREATMENTS PROPOSED  
Apart from dietary patterns, there are other elements in MS management such as exercise, 
drugs, surgery or psychological support. Nevertheless, based on the studies reviewed in the 
current paper, it seems that nutritional treatments play an essential role in MS recuperation. 
More importantly, nutritional therapy should teach to MS patients to have healthy dietary 
patterns in order to prevent future regressions. Between the different nutritional treatments 
reviewed, it is clear that fruits, vegetables, fish, nuts, legumes and whole grain cereals intake are 
directly connected with MS improvements and remissions. However, simply sugar, highly present 
in ultra-processed food, is associated to MS suffering. In terms of nutrients enough protein and 
monounsaturated fats consume should be provided by diet to improve MS status.  
Panagiotakos et al.3 proposed that people who suffer MS would improve their health through diet, 
exercise and lifestyle changes. De Flines et al.44 mention that it would be necessary to pay 
attention to diet, physical activity, obesity, components of MS and insulin resistance in MS 
management. They suggested that lifestyle changes are an adequate method to lead MS 
components and only in the case that this intervention would be not enough, a pharmacological 
mediation should be contemplated. In general, it is thought that dietary patterns could play an 
important role in MS remission. A previous research51 explored the effect of a dietary intervention 
in order to study salt sensitivity on blood pressure. A decrease in sodium intake could be used to 
modulate blood pressure in MS due to a significant reduction in arterial blood pressure was 
detected with a low sodium ingestion. Supplementary, another study52 examined salt sensitivity 
in MS; blood pressure reacted to salt ingestions in an increased way in MS. Interestingly, a 
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reduction in salt ingestions achieved systolic blood pressure decrease in patients with three or 
more MS components. A recent review53 analyzed the evidence of nutritional therapies in MS. 
They determined that a low calorie diet connected with exercise intervention showed the higher 
efficiency; nonetheless they highlighted the importance of life changes in the MS remission.    
Anderssen et al.54 evaluated diverse methods in one year of intervention in male with MS. Exercise 
and diet reduce MS prevalence to 32.6%, isolated diet to 64.7% and exercise alone to 76.5%. Diet 
intervention consisted on individualized nutritional counseling and including energy restriction; 
fish consume and decreased saturate fats and cholesterol intake. Physical activity based on 
endurance exercise and composed of 60 minutes of aerobics, circuit training and fast walking at 
the 60-80 peak heart. Another study55 mentioned that high fruits, vegetables and minimal 
processed cereals intakes are related to a reduced risk of MS while high meat ingestion, highly 
processed cereals and fried food were related with MS. The authors highlighted the magnitude of 
diet quality in MS apparition and evolution. Another review56 proposed that vegetarian and vegan 
diets could improve MS and these dietary patterns are characterized by low energy intake, 
saturated fat and processed fat whereas high fruits, vegetables and fiber ingestions. Esposito and 
Giugliano57 suggested that higher adherence to Mediterranean diet showed less occurrence of 
MS. This dietary pattern, characterized by lower carbohydrate intake and high fat intake could 
contribute to improve MS, particularly blood lipids, insulin resistance and liver perform. Another 
research58 detected a relation between nuts, legumes and seeds consume and a lower risk MS 
suffering.  
Another previous study59 examined the protein content in obese participants for 12 months. They 
were assigned to a high protein diet (1.34 g per kg of BM) or to a standard protein diet (0.8 g per 
kg of BM) and a calorie restriction of 500 kcal per day. Obtaining that high protein group 
reported a higher body weight loss and fat mass loss compared with another group, furthermore 
biochemical parameter were better with the high protein regimen. Besides, 64.5% participants of 
the high protein diet did not fulfill three or more components of MS at the end. As a result 
protein enriched diet could be an instrument in the control of MS. Klemsdal et al.60 examined a 
low glycemic load (LGL) diet in contrast with a low fat diet in participants with different grades. 
After the first three months of intervention, subjects assigned to LGL presented higher weight 
loss and one year after, blood pressure decreased more in LGL diet. They concluded that LGL diet 
could be appropriate with subjects diagnosed with MS.  
Esposito et al.61 commented that nutritional habits similar to Mediterranean diet characterized by 
high fruit and vegetables intake and high monounsaturated fats are inversely associated to MS. 
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They also indicated that drugs treatment presented slightly lower weight loss that lifestyle 
intervention based of nutritional changes. Another study29 suggested that beneficial effects for 
MS could be obtained from diets rich in fruits, vegetables, legumes, whole grains, fish and nuts. 
The authors considered that simple carbohydrates like sugar are directly involved in MS progress 
and highlighted that polyunsaturated and monounsaturated fats could prevent components of 
MS. More interestingly is that authors reported that society needs to create a consciousness of 
the importance of life style components, particularly dietary and physical activity patterns in the 
prevention of MS.  
 
CONCLUSIONS 
On balance, the present study shows MS is a widespread condition in almost all areas. It seems 
that a cluster of factors are involucrate in MS development such as dietary habits, physical 
activity levels, genetic heritage, social economic grade, age, sex, educational level or gut 
microbiota, it would necessary to focus on each one of these elements to determine MS cause. 
Obviously, MS status has consequences on health such as cardiovascular diseases, increased risk 
of some kind of cancers, DM, sleep abnormalities. However, an important effect of MS is physical 
incapacity because it could probably affect to quality of life of the patient. In MS management 
there several treatments involved such as exercise programs, drugs therapies or surgical 
procedures. However, it has been reviewed that nutritional treatment has a notable importance 
in MS recovery, particularly dietary patterns with high intakes of fruits, vegetables, fish, nuts, 
legumes and whole grain cereals intakes are directly connected with MS alleviation. In terms of 
nutrients, an adequate consumes of monounsaturated fats and proteins would be recommended. 
However, more studies with long term follow-up period should be performed to understand MS 
multiple causality, clinical consequences associated to MS and nutritional treatments. 
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